Aluminium-based adjuvants (ABA) are the predominant adjuvants used in human vaccinations. While a consensus is yet to be reached on the aetiology of the biological activities of ABA several studies have identified shape, crystallinity and size as critical factors affecting their adjuvanticity. In spite of recent advances, the fate of ABA following their administration remains unclear. Few if any studies have demonstrated the unequivocal presence of intracellular ABA. Herein we demonstrate for the first time the unequivocal identification of ABA within a monocytic T helper 1 (THP-1) cell line, using lumogallion as a fluorescent molecular probe for aluminium. Use of these new methods revealed that particulate ABA was only found in the cell cytoplasm. Transmission electron microscopy revealed that ABA were contained within vesicle-like structures of approximately 0.5–1 μm in diameter.
Since their inception in the 1920s aluminium based adjuvants (ABA) have remained the predominantly used adjuvants in human vaccinations1. ABA are aluminium salts dispersed in water to form heterogeneous suspensions or gels, of hydrated colloid particles that consist of micron-sized aggregates of 1–20 μm with primary particles in the nano-size range2,3,4. Aluminium oxyhydroxide (AlO(OH)) adjuvants such as the licensed ABA Alhydrogel® (Brenntag Biosector, Denmark)5 are the most commonly used manufactured ABA in clinical vaccinations. AlO(OH)-based adjuvants are principally used owing to being the most well-defined and consistent of the clinically approved ABA and in their ability to adsorb negatively charged protein antigens from aqueous solutions at physiological pH2.
When formulated in vaccine preparations, ABA both potentiate the efficacy of weak antigens and shape the resultant immune response6. Use of antigen only often results in weak immunopotentiation and little or no antibody production7. Whilst the efficacy of ABA is undisputed, a consensus is yet to be reached upon their biological activities in vivo. ABA including aluminium hydroxide preparations are used in vaccinating against diphtheria, hepatitis A and B and against human papilloma virus (HPV) to prevent cervical cancers6,7. An ever intensifying research effort is currently underway to explain the observed adjuvanticity of ABA with several studies highlighting their physicochemical properties as a key determinant. Interestingly it has been shown that nanoparticles of aluminium hydroxide of ca 200 nm elicit more potent adjuvant activities in an in vivo model of murine adjuvanticity, than larger particles in the micron-size range9. The increased adjuvanticity of aluminium hydroxide nanoparticles was explained by their greater ease of uptake by dendritic antigen presenting cells (APCs)9.
Variation of the physicochemical properties of AlO(OH)-based adjuvants via engineering particles with defined shape, size and morphology characteristics has been used in studying their immunopotentiating properties10. Recent research by Sun and co-workers (2013) showed that the design of ordered rod-like AlO(OH) nanoparticles with higher crystallinity resulted in greater cellular uptake of the antigen and increased IL-1β production10. Interestingly, increased production of IL-12 and IL-6 was observed in bone marrow-derived dendritic cells (BMDCs) for the engineered AlO(OH) nanorods, the former being a known polariser of a Th1 response7. Therefore alteration of the physicochemical properties of aluminium hydroxide based adjuvants alone has been shown to shape their immunostimulatory properties both in vivo and in vitro9,10.
Surprisingly, little experimental information has eluded to the potential cellular uptake of ABA or any compartmentalisation of ABA, inside the cell3,11,12,13,14,15. This has been suggested to be critical for the activation and assembly of the Nalp3 inflammasome, driving pro-inflammatory immune responses via secretion of mature interleukin IL-1β and IL-18 cleaved from the prointerleukins by actvated caspase-116,17. Ultrastructural investigations paired with X-ray microanalysis have previously been used to successfully confirm the presence of aluminium in the skin13.
Aluminium hydroxide granulomas from excised subcutaneous nodules were identified in three children ranging in age from 18 to 36 months following injection of a diphtheria, tetanus and pertussis vaccine, adjuvanted with aluminium hydroxide13. Whilst aluminium was identified in the skin the aluminium signal measured was not confined to any intracellular environment and hence evidence of intracellular aluminium was neither inferred by the authors nor could it be established unequivocally13.
Further X-ray based methods have used particle-induced X-ray emission (PIXE) to identify aluminium in quadriceps muscle of Cynomolgus monkeys, following intramuscular administration of a Diphtheria-tetanus vaccine containing 0.6 mg/mL of either AlO(OH) or aluminium hydroxyphosphate (AlPO4) based adjuvants14. Increases in the aluminium concentration were found at a muscular level over scanned areas of 1 mm2 in the injection site, with marked increases identified in muscular lesions following 3 and 6 months post-injection14. No results were included however to show that aluminium was localised within cells.
A study by Rimaniol and co-workers (2004) demonstrated the presence of crystalline inclusions in macrophages exposed to 2 μg/mL aluminium oxyhydroxide (AlO(OH)) adjuvant via transmission electron microscopy (TEM)15. Electron micrographs revealed electron dense material scattered throughout macrophages. In spite of the observations of electron dense material in macrophages, no direct evidence was provided to confirm that those inclusions identified contained particulate AlO(OH)15. A more recent study by Lu & HogenEsch (2013) highlighted the presence of an ABA (Rehydragel™ HPA, USA) in murine macrophages using morin (2,3,4,5,7-pentahydroxy- flavone) staining11.
An earlier investigation using the same method found ABA internalised in epithelioid macrophages and multinucleated giant cells in rhesus macaque skin sections12. No autofluorescence controls were shown in either paper however and the influences of the protein antigens alone were not addressed11,12. Morin is also known to bind to magnesium (Mg2+) and calcium (Ca2+) ions to produce false positives18. A hydrochloric acid pre-rinse, prior to staining is frequently used to account for such. The resultant acidity however, is likely to promote the formation of soluble Al3+ increasing the likelihood of the dissolution of aluminium bound in tissue and its possible migration throughout the tissue19.
Investigations monitoring the potential cellular uptake of ABA have preferentially labelled the adsorbed protein antigen (often ovalbumin (OVA)) with the amine-reactive derivative of the fluorescein dye, fluorescein isothiocyanate (FITC)9,10,20,21. Following adsorption of an ABA with FITC-labelled OVA, the presence of the adjuvant has been inferred intracellularly in cultured DC-lines by use of confocal microscopy20,21, fluorescence microscopy9 and flow cytometry10,20,21. Whilst the presence of the OVA protein antigen has been observed intracellularly within APCs9,20,21, whether the adsorbed ABA is internalised or not remains to be determined as the use of FITC only allows for the identification of internalised antigen.
Pre-labelling AlO(OH) adjuvants with FITC via the use of pre-incubation with organic moieties10 may also result in changes to the surface of the particulates as well as modifications to their hydroxyl functionality and size. This may in turn affect their uptake as the variation of such physicochemical properties of ABA has been shown to dramatically affect their cellular uptake8,9,10. Furthermore, potential modifications to the endocytic/phagocytic pathways of internalisation following conjugation of the ABA to FITC-OVA cannot be ruled out.
Use of AlO(OH) (Alhydrogel, Brenntag) formulated with the chimaeric Ealpha green fluorescent protein (EαGFP) demonstrated an increase in antigen uptake compared to uptake of EαGFP alone via the detection of GFP using flow cytometry22. As with the use of FITC only the presence of the antigen could be inferred inside the cell of which the authors summarised that ABA provide an enhanced delivery mechanism of the antigen only whilst not addressing potential uptake of the adjuvant by dendritic cells (DCs)22. Additional studies have supported these conclusions with crystals of the ABA being suggested to not enter the cell and rather aid in the transport of the antigen across DC membranes with activation of the Nalp3 inflammasome being dispensable for triggering subsequent immune responses23.
Few if any studies within the literature have therefore shown the direct monitoring of the intracellular ABA content of various immune cells and a consensus upon the biological activates of ABA has yet to be reached16,17. Herein we report for the first time the unequivocal identification of intracellular AlO(OH) particles both for a clinically approved and an experimental AlO(OH)-based adjuvant in a monocytic T-helper 1 (THP-1) cell line. Positive identification of particulate ABA was observed intracellularly by use of the planar tridentate ligand lumogallion [4-chloro-3-(2,4-dihydroxyphenylazo)-2-hydroxybenzene-1-sulphonic acid] as a fluorescent molecular probe for aluminium24.
Lumogallion is commonly used to detect the presence of aluminium at low concentrations in natural waters with a limit of detection of ca 2 nM25 and has been used extensively for the identification of the metal ion in plant roots26,27. Lumogallion has been suggested to act as a planar tridentate ligand for aluminium with binding of the metal ion via the two phenolic oxygen ions and the azo (N = N) group of lumogallion establishing a 1:1 stoichiometry of the complex24. Lumogallion is known to bind to the soluble ionic Al3+ form of aluminium, with complex formation resulting in an emission intensity at ca 590 nm (orange fluorescence) upon an excitation wavelength of ca 500 nm28.
Unlike morin, lumogallion is not known to be prone to false positives including metal ions commonly found in physiological media including magnesium, calcium24 and iron25. In combination with fluorescence microscopy, use of the complementary techniques, confocal microscopy and TEM further aided to confirm the intracellular presence of particulate aluminium at a physiologically relevant pH, furthering our understanding into the role of ABA in clinical vaccinations.
Cell culture and fixation
All chemicals were from Sigma Aldrich, UK, unless otherwise stated. THP-1 cells (ATCC TIB-202, LGC Standards, UK) were cultured in complete R10 medium which consisted of RPMI 1640 medium supplemented with 10% foetal calf serum (EU grade) and 100 μg/mL gentamicin (both from PAA laboratories, Linz, Austria). All cells were cultured at 37°C in a humidified atmosphere containing 5% CO2.
Native THP-1 cells (i.e. those containing no ABA) were cultured in the presence of complete R10 medium only, whilst those cell treatments containing the ABA were co-cultured in R10 media containing 50 or 200 μg/mL of either the aluminium oxyhydroxide-based (AlO(OH)) adjuvant, AlO(OH)Sigma (A8222, aluminium hydroxide gel colloidal suspension, Sigma Aldrich, UK) or Brenntag's Alhydrogel® (2%), AlO(OH)Brenntag (Brenntag Biosector, Denmark) for 24 h. Each of the cell treatments were cultured in triplicate in 96 well plates with a final volume of 200 μL per well. Following incubation the triplicates made from each of the co-culture conditions were pooled and the cells were subsequently centrifuged and washed with phosphate buffered saline (PBS).
Cells from each of the treatments were then fixed by transfer into 1% paraformaldehyde (PFA) and incubating for 24 h, at ambient temperature. The number of intact cells after fixation was counted using an Accuri C6 flow cytometer. After counting, each of the cell treatments were re-suspended in 70% v/v ethanol in order to prevent over fixation of the cells resulting in the reduced penetration of histochemical reagents.
Paraffin and resin embedding of THP-1 cells
Full details concerning paraffin and resin embedding of THP-1 cells for sectioning are detailed in the supplementary methods. Briefly, PFA fixed THP-1 cells co-cultured in R10 medium in the absence or presence of AlO(OH)Sigma were pre-embedded into agar and dehydrated fully through an ethanol gradient. For paraffin embedding the resultant agar-cell blocks were cleared with Histo-Clear and infiltrated with paraffin wax. 2 μm sections were prepared by use of a rotary microtome and the agar-cell sections were rehydrated back into ultrapure water prior to staining. THP-1 cells for resin embedding were dehydrated as above and then gradually infiltrated with Spurr resin. Polymerised resin blocks were sectioned at 100 nm by use of an automated ultramicrotome.
Fixed THP-1 cells co-cultured in complete R10 medium in the presence or absence of 50 or 200 μg/mL AlO(OH)Brenntag adjuvant (24 h) were pelleted and mixed with 40 μl Tissue-Tek® O.C.T compound, Sakura® Finetek cryoprotection medium (VWR, Stockholm, Sweden). Cells were then transferred to a 10 × 10 × 5 mm Tissue-Tek® Cryomold® (HistoLab®, Gothenburg, Sweden) and frozen on dry ice. The frozen cells were sectioned at 6 μm using a Leica CM 3050 cryostat and mounted on Menzel SuperFrost® Plus glass slides (VWR, Stockholm, Sweden). Slides were stored at −80°C until further processing.
Lumogallion staining of cell sections
Agar-cell sections were de-waxed and rehydrated by transferring the slides in a holder (up to 12 at a time) through 250.0 mL of the following in glass staining dishes: Histo-Clear for 3 min, fresh Histo-Clear for 1 min, 100% ethanol for 2 min, 95, 70, 50 & 30% v/v ethanol for 1 min and finally ultrapure water for 35 s. Sides were agitated in each solution and blotted dry on tissue paper between each stage. Rehydrated cell sections were immediately placed into either 100 μM lumogallion (TCI Europe N.V. Belgium) buffered in 50 mM PIPES, pH 7.4 or the PIPES-buffer alone for auto-fluorescence analyses and were then covered and incubated at ambient temperature in the dark for 24 h.
Following 24 h the slides were removed, blotted dry and for the lumogallion stained sections only, were rinsed by gentle agitation in 50 mM PIPES, pH 7.4 for 2 min. Slides were rinsed in ultrapure water for 2 min, air dried and finally mounted using ProLong® Gold Antifade Reagent with 4′,6-diamidino-2-phenylindole, dihydrochloride (DAPI) (Life Technologies, UK). Slides were stored horizontally for 24 h at 4°C to allow the mounting media to fully cure, prior to their analysis via fluorescence microscopy. Cryosectioned THP-1 cells were thawed for 10 min at ambient temperature and then placed into either PIPES-buffer alone or PIPES-buffered lumogallion. Cryosectioned THP-1 cells were stained and mounted in the exact same way as the agar-cell sections.
For specific details pertaining to fluorescence microscopy, please refer to the supplementary methods. All cell images were obtained at ×1000 magnification using a ×100 Plan-Fluorite oil immersion objective (Olympus, UK) in combination with low auto-fluorescence immersion oil (Olympus immersion oil type-F). The exposure settings for the lumogallion analyses were fixed at 1 s with fixed light transmission values. Images were obtained using the CellD software (Olympus, Soft Imaging Solutions, GmbH) package and fluorescent and light channels were overlaid by use of Photoshop (Adobe systems Inc. USA).
Transmission electron microscopy (TEM)
Grids were stained with 2% w/v uranyl acetate as described in the supplementary methods. Samples for TEM were viewed on a JEOL 1230 transmission electron microscope operated at 100.0 kV (spot size 2), equipped with a Megaview III digital camera from Soft Imaging Systems (SIS). Images were obtained on the iTEM universal TEM imaging platform software. Measurements of intracellular ABA particles were made using the CellD software package and the final editing of electron micrographs for publication was achieved using Photoshop (Adobe systems Inc. USA).
Identification of intracellular AlO(OH) particles in THP-1 agar-cell sections
Preliminary experiments in which ABA only (AlO(OH)Sigma and AlO(OH)Brenntag) were embedded into agar-paraffin and subsequently stained with lumogallion for 24 h (as with THP-1 cell sections) proved successful in positively identifying both ABA as evidenced by an orange fluorescence emission (Fig. 1).
Native THP-1 cells grown in R10 medium in the presence or absence of AlO(OH)Sigma showed green autofluorescence in the absence of the fluor lumogallion (Fig. 2a). Analysis of THP-1 cells containing 200 μg/mL AlO(OH)Sigma revealed that those structures identified produced clear DAPI fluorescence (Fig. 2b–c) confirming the presence of nuclei and hence the positive identification of THP-1 cells. Overlaying of the light channel elucidated that the green autofluorescence observed was most intense within the cell cytoplasm (Fig. 2d).
In order to investigate whether AlO(OH)Sigma was taken up by THP-1 cells, the cells were co-cultured in the presence or absence of the ABA, sectioned and then stained with lumogallion. Lumogallion staining of native THP-1 cells revealed a dull orange/brown fluorescence for the cells (Fig. 3a) with DAPI fluorescence confirming the presence of cell nuclei (Fig. 3b & c). Overlaying of the light channel demonstrated that only cells were fluorescing with no detectable fluorescence of the agar-support medium (Fig. 3d).
THP-1 cells co-cultured with 50 μg/mL of the AlO(OH)Sigma adjuvant and stained with lumogallion, produced bright orange fluorescence at their periphery (Fig. 3e) and clear DAPI fluorescence (Fig. 3f). Merging of the fluorescence and light channels revealed that the bright orange fluorescence of the AlO(OH)Sigma adjuvant (Fig. 3g, magnified inset) was contained only within the cytoplasm of THP-1 cells (Fig. 3h). Extracellular ABA was readily identifiable for lumogallion stained THP-1 cells co-cultured with 200 μg/mL AlO(OH)Sigma (Fig. 3i). As with THP-1 cells co-cultured with 50 μg/mL AlO(OH)Sigma, spherical particulate-like structures were identified intracellularly in THP-1 cells exhibiting DAPI fluorescence (Fig. 3j & k). The combination of light and fluorescence channels depicted the clear localisation of an orange fluorescence emission within cell cytoplasm and not within cell nuclei (Fig. 3l).
Spherical particulates of AlO(OH)Sigma identified intracellulary in THP-1 cells proved to be consistent in size whether co-cultured with 50 or 200 μg/mL of the ABA. Spherical ABA particulates with an average outer diameter of 0.88 ± 0.17 μm and 0.90 ± 0.14 μm were observed (mean ± SD, n = 16) intracellulary in THP-1 cells co-cultured in the presence of 50 and 200 μg/mL of the AlO(OH)Sigma adjuvant, respectively (Table 1).
Identification of intracellular AlO(OH) particles in cryosectioned THP-1 cells
We next examined whether the clinically approved AlO(OH)Brenntag adjuvant was internalised in THP-1 cells co-cultured in the presence or absence of 50 or 200 μg/mL of the ABA via fluorescence microscopy. Analysis of cryo-sectioned THP-1 cells showed a green autofluorescence of the cells with clear DAPI fluorescence both in the presence or absence of the AlO(OH)Brenntag adjuvant. For lumogallion stained native THP-1 cells cultured in the presence of R10 medium only, a dull orange/brown fluorescence was observed (Fig. 4a). DAPI fluorescence confirmed the presence of cell nuclei (Fig. 4b) which overlaid with the lumogallion fluorescence (Fig. 4c) and light channels confirmed the presence of a dull orange/brown fluorescence within the cytoplasm of THP-1 cells (Fig. 4d).
Cryosectioned THP-1 cells co-cultured in the presence of 50 μg/mL of the AlO(OH)Brenntag adjuvant and stained with lumogallion revealed intracellular particulates of the ABA as identifiable by the observed orange fluorescence emission (Fig. 4e). Overlay of the DAPI fluorescence channel (Fig. 4f) confirmed that THP-1 cells had internalised AlO(OH)Brenntag particulates, predominantly within their cytoplasm with no evidence of ABA being present within cell nuclei (Fig. 4g, magnified inset). Overlay of the light channel confirmed that positive lumogallion staining for ABA was only notable within cell cytoplasm with little trace of extracellular ABA (Fig. 4h).
Similar observations were noted for THP-1 cells co-cultured in the presence of 200 μg/mL AlO(OH)Brenntag, with a strong orange fluorescence emission being observed at the periphery (Fig. 4i) of positively identified THP-1 cells (Fig. 4j & k). Overlay of the light with the lumogallion and DAPI fluorescence channels confirmed the presence of a strong orange fluorescence emission within the cell cytoplasm (Fig. 4l, magnified inset). Identification of individual particulate-like structures was sometimes hindered due to the intense orange fluorescence observed. Measurements of intracellular AlO(OH)Brenntag particulates within THP-1 cells was however possible with cells co-cultured in 50 or 200 μg/mL of the ABA giving average outer diameters of 1.09 ± 0.23 μm and 1.00 ± 0.10 μm (mean ± SD, n = 16), respectively. The dimensions of intracellular AlO(OH)Brenntag-based particulates was therefore in close agreement to THP-1 cells co-cultured in the presence of the AlO(OH)Sigma adjuvant (Table 1).
The complementary use of transmission electron microscopy confirmed the presence of intracellular particulate AlO(OH) adjuvant within THP-1 cells
To support any observations of intracellular AlO(OH) particulates within THP-1 cells, cells co-cultured in the presence or absence of the AlO(OH)Sigma adjuvant were embedded into resin and analysed by transmission electron microscopy (TEM). TEM of native THP-1 cells cultured in R10 medium only allowed for the detection of cells (Fig. 5a) with clear distinction between cell cytoplasm and nuclei (Fig. 5a–c). Native THP-1 cells were found to have a dense granular cytoplasm with the entire cell free of any particulate material (Fig. 5c).
For those cells co-cultured in the presence of 50 μg/mL of the AlO(OH)Sigma adjuvant, electron dense particulates were observed within the cytoplasm of THP-1 cells (Fig. 5d). Higher magnifications revealed the presence of needle-like particulates (Fig. 5e & f) in aggregates with an average size of 1.04 ± 0.35 μm (mean ± SD, n = 16) (Table 1). Those particulates observed were found to be present in the cell cytoplasm only and contained within vesicle-like structures.
THP-1 cells co-cultured with 200 μg/mL of the AlO(OH)Sigma adjuvant revealed aggregated particulates of the ABA solely present within the cell cytoplasm (Fig. 5g). Extracellular ABA was also found within the agar support medium as with the lumogallion fluorescence analyses of the cells (Fig. 3i & Fig. 4i). Higher magnifications revealed that internalised AlO(OH) particulates were found in vesicle-like structures (Fig. 5h & i) as with cells co-cultured in lower concentrations of the ABA with an average size of 1.20 ± 0.26 μm (mean ± SD, n = 16) (Table 1). It was also noted that the cell cytoplasm of THP-1 cells co-cultured in the presence of the ABA (Fig. 5d & Fig. 5g) exhibited a loss of integrity in comparison to native cells (Fig. 5a).
Confocal microscopy confirms the presence of intracellular AlO(OH) in non-sectioned THP-1 cells
To ascertain whether AlO(OH)Brenntag was internalised within THP-1 cells whilst avoiding sectioning and the potential loss or disturbance of intracellular particulates, cells cultured in the absence or presence of the ABA were stained with lumogallion and analysed by confocal microscopy. Cells were counter-stained with DAPI for the identification of cell nuclei. Merging of both DAPI and lumogallion fluorescence channels for THP-1 cells co-cultured with 50 μg/mL AlO(OH)Brenntag showed positive lumogallion staining for aluminium observed as spherical particulates contained within the cytoplasm of cells with a lack of particulate material localised in cell nuclei (see Supplementary Fig. 1a). Merging of the two channels for native THP-1 cells revealed positive DAPI staining only, confirming the presence of cell nuclei (see Supplementary Fig. 1b).
We have investigated whether a clinically approved AlO(OH)Brenntag adjuvant and an experimental AlO(OH)Sigma adjuvant of similar formulation can enter a monocytic THP-1 cell line. Whilst studies have pertained to the presence of ABA inside APCs and cells of monocytic origin, none have shown the unequivocal presence of intracellular ABA6,12,15,21,29. A recent study has demonstrated the presence of in vivo injected aluminium adjuvant in rat at a muscular as opposed to a cellular level using lumogallion30. The direct identification of intracellular particulates of AlO(OH)-based adjuvants were therefore sought via the use of lumogallion as a sensitive molecular probe for aluminium24,25. The use of lumogallion also ensured that aluminium was detected inside cells as opposed to the identification of molecular markers which in themselves may be internalised with antigen in the absence of the attached ABA, or may have an influence upon their cellular uptake.
It was not known whether lumogallion could bind to particulate ABA to provide a characteristic fluorescence emission at ca 590 nm (orange)28. Whilst easily distinguishable from the agar support medium, those AlO(OH) particulates observed were found to fluoresce at low intensity (Fig. 1). As AlO(OH) possesses a crystalline structure with a degree of symmetry31, a high proportion of available aluminium sites (Al3+) will be held internally forming crystal contacts, thereby occluding their binding to lumogallion with only external sites able to bind. In spite of these observations however both the clinical and experimental AlO(OH) formulations could be detected. To our knowledge this is the first report of the use of lumogallion for the unequivocal detection of intracellular ABA.
For the investigation of the potential intracellular uptake of AlO(OH), a cultured human THP-1 cell line of monocytic origin was used in order to investigate a relevant in vitro model used in separate reports of the effects of ABA on mitochondrial activity and phagosomal pathways of phagocytosing cells32. Morin has previously been used to detect internalised ABA conjugated to antigens11 via a green fluorescence emission at ca 510 nm18. Therefore the establishment of autofluorescence of any given cell line is critical in order to rule out the possibility of the green fluorescence signal observed being attributable to the cellular components rather than that of internalised ABA.
For the analysis of cell sections under the lumogallion fluorescence channel, a long pass emission filter was used allowing emitted wavelengths of or greater than 510 nm to pass through hence explaining the observed green autofluorescence for cells (Fig. 2). Due to the aforementioned sensitivity issues of morin binding to divalent metal ions to produce false positives, lumogallion provides an attractive approach to the identification of ABA with high sensitivity at a physiologically relevant pH.
A uniform orange fluorescence was observed for cells co-cultured in the presence of AlO(OH) in regions of the cells found to be devoid of particulate AlO(OH). The fluorescence observed was found to be less intense than that of positively identified particulates (e.g. Fig. 4e) but more intense than the dull orange/brown fluorescence observed for native cells (e.g. Fig. 4a), likely explained by the use of a long pass emission filter. Therefore we cannot rule out the possibility of soluble Al3+ being present within cell cytoplasm and/or nuclei, as inferred by the lumogallion analyses. Particulates for both the clinically approved and experimental AlO(OH) formulations were localised within the cell cytoplasm of THP-1 cells. These observations were supported via TEM in which particulate AlO(OH)Sigma was localised within vesicle-like structures in the cytoplasm of THP-1 cells only (Fig. 5), in similar size aggregates of ca 1 μm (Table 1).
Fluorescence microscopy and TEM both required cells to be sectioned to allow for the exposure of intracellular AlO(OH) to lumogallion and uranyl acetate, respectively. To rule out the possibility of particulate AlO(OH) being observed in THP-1 cells as a result of artefacts arising from the sectioning and embedding procedures33, confocal microscopy of whole cells was performed. Confocal microscopy of living cells stained with lumogallion demonstrated the presence of particulate AlO(OH) within the cell cytoplasm only thereby confirming that ABA were deposited intracellularly and did not arise from extracellular particulates being deposited on the surface of newly exposed cell sections (see Supplementary Fig. 1).
Research investigating the phagosomal pathways of THP-1 cells in the presence of AlO(OH) implicated that phagocytosis of particulate ABA results in the entrapment of particulate ABA in phagosomes32. It was concluded that the subsequent maturation of phagosomes into phagolysosomes resulted in the acidification of their interior causing the pH to fall to ca 4.5 to 5. Under these acidic conditions it is likely that the solubility of the internalised ABA will be increased32 resulting in the greater availability of intracellular Al3+. Interestingly, for the unequivocal identification of intracellular AlO(OH) demonstrated herein, a more intense orange fluorescence emission was observed for intracellular versus extracellular ABA particulates (e.g., Fig. 3e & 4i). As lumogallion is known to bind 1:1 with Al3+ a greater availability of the metal ion would result in increased complex formation, thereby explaining the intense fluorescence observed for intracellular AlO(OH). Our results therefore support the phagocytosis of ABAs by monocytic cells.
A study investigating the uptake of ovalbumin adsorbed onto the surface of alpha aluminium oxide nanoparticles (α-Al2O3-OVA) by DCs showed electron dense particles internalised within autophagosomes and autlolysosomes by TEM21. Those aggregates observed were found to be ca 1 μm in size21 and therefore in the same size range for intracellular AlO(OH) shown herein. These results taken together suggest that the intracellular uptake of ABA by cells of monocytic origin, occurs via phagocytotic mechanisms21,32. Within this research we have shown that lumogallion provides an excellent molecular probe for ABA, allowing for the fate of ABA to be determined in a relevant in vitro cell line32.
The adsorption of inherent antigen in the form of serum proteins including bovine serum albumin included in the 10% foetal calf serum used for cell culture, may have affected the uptake of the AlO(OH) adjuvants used within this study. Further studies are currently underway to address the influences of co-adsorbed antigens on the cellular uptake of aluminium adjuvants. In addition we now aim to ascertain whether internalised aluminium adjuvant has antigen associated with it. The unequivocal identification of intracellular ABA may prove essential for the understanding of the adjuvanticity of ABAs administered in human vaccinations.
Glenny, A. T., Pape, C. G., Waddington, H. & Wallace, W. The antigenic value of the toxin-antitoxin precipitate of Ramon. J. Pathol. Bacteriol. 29, 31–40 (1926).
Lindblad, E. B. Aluminium compounds for use in vaccines. Immunol. Cell Biol. 82, 497–505 (2004).
Exley, C., Siesjo, P. & Eriksson, H. The immunobiology of aluminium adjuvants: how do they really work? Trends Immunol. 31, 103–109 (2010).
Hem, S. L. & HogenEsch, H. Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation. Expert Rev. Vaccines 6, 685–698 (2007).
Hem, S. L., Johnston, C. T. & HogenEsch, H. Imject® Alum is not aluminum hydroxide adjuvant or aluminum phosphate adjuvant. Vaccine 25, 4985–4986 (2007).
Hogenesch, H. Mechanism of immunopotentiation and safety of aluminum adjuvants. FIMMU 3, 406 (2012).
Reed, S. G., Orr, M. T. & Fox, C. B. Key roles of adjuvants in modern vaccines. Nat. Med. 19, 1597–1608 (2013).
Kanchan, V. & Panda, A. K. Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response. Biomaterials 28, 5344–5357 (2007).
Li, X. R., Aldayel, A. M. & Cui, Z. R. Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles. J. Control Release 173, 148–157 (2014).
Sun, B. B. et al. Engineering an Effective Immune Adjuvant by Designed Control of Shape and Crystallinity of Aluminum Oxyhydroxide Nanoparticles. ACS Nano 7, 10834–10849 (2013).
Lu, F. J. & HogenEsch, H. Kinetics of the inflammatory response following intramuscular injection of aluminum adjuvant. Vaccine 31, 3979–3986 (2013).
Morefield, G. L. et al. An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic shock. J. Immune Based Ther. Vaccines 6, 5 (2008).
Slater, D. N., Underwood, J. C. E., Durrant, T. E., Gray, T. & Hopper, I. P. Aluminium hydroxide granulomas: light and electron microscopic studies and X-ray microanalysis. Brit. J. Dermatol. 107, 103–108 (1982).
Verdier, F. et al. Aluminium assay and evaluation of the local reaction at several time points after intramuscular administration of aluminium containing vaccines in the Cynomolgus monkey. Vaccine 23, 1359–1367 (2005).
Rimaniol, A. C. et al. Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type. Vaccine 22, 3127–3135 (2004).
Franchi, L. & Nunez, G. The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1 beta secretion but dispensable for adjuvant activity. Eur. J. Immunol. 38, 2085–2089 (2008).
Eisenbarth, S. C., Colegio, O. R., O'Connor, W., Sutterwala, F. S. & Flavell, R. A. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453, 1122–1126 (2008).
Browne, B. A., McColl, J. G. & Driscoll, C. T. Aluminum speciation using morin .1. Morin and its complexes with aluminum. J. Environ. Qual. 19, 65–72 (1990).
Exley, C. Aluminium in the brain and heart of the rainbow trout. J. Fish Biol. 48, 706–713 (1996).
Uto, T. et al. Comparative activity of biodegradable nanoparticles with aluminum adjuvants: Antigen uptake by dendritic cells and induction of immune response in mice. Immunol. Lett. 140, 36–43 (2011).
Li, H. Y., Li, Y. H., Jiao, J. & Hu, H. M. Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response. Nat. Nanotechnol. 6, 645–650 (2011).
Ghimire, T. R., Benson, R. A., Garside, P. & Brewer, J. M. Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitro. Immunol. Lett. 147, 55–62 (2012).
Flach, T. L. et al. Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity. Nat. Med. 17, 479–488 (2011).
Wu, J. et al. Determination of serum aluminum using an ion-pair reversed-phase high-performance liquid chromatographic-fluorometric system with lumogallion. J. Chromatogr B. 663, 247–253 (1995).
Hydes, D. J. & Liss, P. S. Fluorimetric method for determination of low concentrations of dissolved aluminum in natural-waters. Analyst 101, 922–931 (1976).
Kataoka, T., Mori, M., Nakanishi, T. M., Matsumoto, S. & Uchiumi, A. Highly sensitive analytical method for aluminum movement in soybean root through lumogallion staining. J. Plant Res. 110, 305–309 (1997).
Silva, I. R. et al. Aluminum accumulation at nuclei of cells in the root tip. Fluorescence detection using lumogallion and confocal laser scanning microscopy. Plant Physiol. 123, 543–552 (2000).
Ren, J. L., Zhang, J., Luo, J. Q., Pei, X. K. & Jiang, Z. X. Improved fluorimetric determination of dissolved aluminium by micelle-enhanced lumogallion complex in natural waters. Analyst 126, 698–702 (2001).
Hornung, V. et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9, 847–856 (2008).
Kashiwagi, Y., Maeda, M., Kawashima, H. & Nakayama, T. Inflammatory responses following intramuscular and subcutaneous immunization with aluminum-adjuvanted or non-adjuvanted vaccines. Vaccine 32, 3393–3401 (2014).
Shirodkar, S., Hutchinson, R. L., Perry, D. L., White, J. L. & Hem, S. L. Aluminum compounds used as adjuvants in vaccines. Pharm. Res. 7, 1282–1288 (1990).
Ohlsson, L. et al. Aluminium based adjuvants and their effects on mitochondria and lysosomes of phagocytosing cells. J. Inorg. Biochem. 128, 229–236 (2013).
Babourina, O. & Rengel, Z. Uptake of aluminium into Arabidopsis root cells measured by fluorescent lifetime imaging. Ann. Bot. 104, 189–195 (2009).
This research is supported financially by the UK Medical Research Council (MRC). The Dwoskin Foundation is also thanked for funding. Karen Walker is thanked for help with TEM. Emma Sandén is acknowledged for methodological advice for the cryosectioning of THP-1 cells. Dr Andreas Svensson is thanked for help with the confocal microscope.
The authors declare no competing financial interests.
Electronic supplementary material
About this article
Cite this article
Mold, M., Eriksson, H., Siesjö, P. et al. Unequivocal identification of intracellular aluminium adjuvant in a monocytic THP-1 cell line. Sci Rep 4, 6287 (2014). https://doi.org/10.1038/srep06287
Histochemistry and Cell Biology (2019)
Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action
Allergy, Asthma & Clinical Immunology (2018)
Scientific Reports (2018)
Sequestering of damage-associated molecular patterns (DAMPs): a possible mechanism affecting the immune-stimulating properties of aluminium adjuvants
Immunologic Research (2017)
Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations
Scientific Reports (2016)